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Macroautophagy (autophagy) is a cellular pathway facilitating several critical functions.
First, autophagy is a major pathway of degradation. It enables elimination of microbes that
have invaded intracellular compartments. In addition, it promotes degradation of damaged
cellular content, thereby acting to limit inﬂammatory signals. Second, autophagy is a major
trafﬁcking pathway, shuttling content between the cytosol and the lysosomal compartment.
Given these two key roles, autophagy can have signiﬁcant and sometimes unexpected con-
sequences on mechanisms that initiate robust immunity. Here, we will discuss the impact
of autophagy on pathways of innate and adaptive immune responses including microbe
elimination, inﬂammatory cytokine production, antigen processing andT and B lymphocyte
immunity.
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Macroautophagy (referred herein as autophagy) is a process that
involves the formation of an autophagosome, a double membrane
vesicle, which is trafﬁcked to lysosomes where autophagosomal
contents are degraded. Autophagy is considered both a major
pathway of degradation, providing an alternative to the protea-
some,anda signiﬁcant trafﬁckingpathwaybetween the cytosol and
lysosomal compartments. Activating autophagy mostly occurs via
serine/threonine kinase,mammalian target of rapamycin (mTOR)
that impedes autophagy by binding and inactivating the UNC-
51-like kinase (ULK)1/2 kinase. Signaling via the ULK1/2 kinase
complex is critical for recruiting autophagy-related gene (ATG)
proteins to the site of autophagosome biogenesis (Jung et al.,
2010; Weidberg et al., 2011). One ATG of particular importance is
Atg8 (microtubule-associated light chain 3, LC3 in mammals), a
widely used marker of autophagosomes. LC3 acts in autophago-
some expansion and closure (Nakatogawa et al., 2007), in addition
to selectively recruiting autophagosomal cargo (Noda et al., 2008).
Prior to association with the autophagosome, LC3 is conjugated
to phosphatidylethanolamine by a series of reactions that involves
Atg7, Atg3 and an Atg5–Atg12–Atg16 complex (Tanida et al.,
2004). Other critical contributors to autophagy are phosphatidyli-
nositol kinase Vsp34 and Beclin 1, that promote autophagosomal
membrane and fusion events (Liang et al., 2008; Matsunaga et al.,
2009; Zhong et al., 2009). Here, we will discuss examples of the
contribution of the autophagy pathway to innate (Figure 1) and
adaptive (Figure 2) effectormechanisms that are critical for robust
immunity.
AUTOPHAGY AND INNATE EFFECTOR MECHANISMS
Autophagy is an innate effector mechanism that eliminates intra-
cellular pathogens. Autophagy is induced downstream of sig-
naling by “danger” receptors including Toll like receptors (TLR;
Xu et al., 2007; Delgado et al., 2008), retinoic acid inducible
gene I-like receptors (RLR; Yano et al., 2008; Cooney et al.,
2010; Travassos et al., 2010), and alarmins (Tang et al., 2010).
“Xenophagy”describes the process bywhich intracellularmicrobes
are selectively degraded by autophagy (Levine, 2005). Xenophagy
eliminates bacteria that access the cytosol including Streptococ-
cus pyogenes (Nakagawa et al., 2004) and Mycobacterium tuber-
culosis (Gutierrez et al., 2004). Vacuolar bacteria are also tar-
geted. Following RAW cell infection with M. tuberculosis var.
bovis bacillus Calmette–Guerin (BCG), autophagy facilitates the
fusion of mycobacteria containing vacuoles with late endo-
somes/lysosomes to promote mycobacteria degradation (Singh
et al., 2006). Salmonella-containing vacuoles are targeted by LC3
(Birminghamet al., 2006) and can be engulfed by autophagosomes
(Kageyama et al., 2011). Interestingly, recruitment of autophagy
machinery to damaged bacterial vacuoles involves the exposure
of host sugar residues that attract receptor galectin 8 (Thurston
et al., 2012). Xenophagy also facilitates removal of viral pathogens.
One example is the degradation of the Sindbis virus capsid by
the autophagy pathway (Orvedahl et al., 2010). Autophagy can
also impair viral replication by trafﬁcking cytosolic viral repli-
cation products to the endolysosomal compartment where they
are detected by TLR and a type I interferon (IFN) response is trig-
gered. This is the case for vesicular stomatitis virus (VSV) infection
of plasmacytoid dendritic cells (pDC; Lee et al., 2007). Given its
role in anti-viral defense, many viruses encode proteins to disable
autophagy. Gammaherpes virus 68 (Ku et al., 2008), inﬂuenza
A virus (Gannage et al., 2009), herpes simplex virus-1 (HSV-1;
Orvedahl et al., 2007), human cytomegalovirus (Chaumorcel et al.,
2012), and human immunodeﬁciency virus (HIV;Kyei et al., 2009)
are examples of viruses that encode proteins to block autophagy
initiation by interfering with beclin 1 activity. Other interest-
ing examples of viral interference with the autophagy pathway
include Kaposi’s sarcoma-associated herpesvirus encoded Fadd-
like interleukin-1 beta-converting enzyme (FLICE)-like inhibitor
protein that blocks interaction between LC3 and Atg4 (Lee et al.,
2009) and HIV nef that prevents autophagosomal maturation
(Kyei et al., 2009). Like viruses, bacteria also subvert the autophagy
pathway. L. monocytogenes, via the expression of ActA, recruits
host proteins to its surface to disguise itself from autophagic
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FIGURE 1 | Role of autophagy during innate immunity. “Xenophagy”
eliminates intracellular microbes. Autophagy limits inﬂammatory cytokine
production by ensuring removal of dysfunctional organelles, including
mitochondria. Accumulation of damaged mitochondria results in increased
reactive oxygen species (ROS) and the escape of mitochondrial DNA into
the cytosol. These are triggers of the inﬂammasome and interleukin-1β
(IL-1β) production. Inﬂammasomes are targeted for degradation by
autophagy. Proteins in the autophagy machinery bind to and inhibit signaling
of key proteins in the type I interferon pathway, retinoic acid inducible
gene-I (RIG-I) and the signaling molecule IFNβ promoter stimulator-1 (IPS-1).
recognition (Yoshikawa et al., 2009). Similarly, Shigella hides from
the autophagy machinery by expressing IcsB, that inhibits Atg5
binding to the Shigella surface (Ogawa et al., 2005). In summary,
autophagy is a major mode of innate immune defense against
intracellular pathogens.
Autophagy participates in the control of pro-inﬂammatory
cytokine cascades. Many examples illustrate a shutdown in
autophagy results in excessive inﬂammatory cytokine produc-
tion. This is particularly well described for interleukin (IL)-1β
and IL-18, where the absence of autophagy exacerbates their
secretion by murine macrophages when stimulated with pro-
inﬂammatory compounds. Speciﬁcally, this has been described for
beclin1+/− (Nakahira et al., 2011),LC3b−/− (Nakahira et al., 2011),
Atg16L1−/− (Saitoh et al., 2008), and Atg7−/− (Saitoh et al., 2008)
macrophages or following expression of inactive Atg4B or due to
treatmentwith the chemical autophagy inhibitor 3-methyladenine
(3-MA; Saitoh et al., 2008; Harris et al., 2011). Enhanced secretion
of IL-1β also occurs when human peripheral blood mononuclear
cells are stimulated in the presence of an impaired autophagy path-
way due to treatment with 3-MA (Crisan et al., 2011). Conversely,
stimulation of murine DC with rapamycin suppresses IL-1β pro-
duction in response to inﬂammatory stimuli (Harris et al., 2011).
FIGURE 2 | Autophagy modulation of adaptive immunity. Autophagy is
a signiﬁcant trafﬁcking pathway for the delivery of cytosolic antigen to the
MHCII loading compartment in antigen presenting cells. In addition,
proteins in the autophagy machinery contribute to phagocytosis of
extracellular antigen. In lymphocytes, the role of autophagy in eliminating
damaged organelles promotes cell survival.
Rapamycin administration in vivo, inhibits the detected increase
in IL-1β but not IL-12, in the serum 4 h following lipopolysaccha-
ride (LPS) treatment (Harris et al., 2011). Not all stimuli provoke
excessive IL-1β secretion in the absence of autophagy. Stimuli that
do include LPS, or treatment of LPS-primed macrophages with
adenosine 5’-triphosphate (ATP) or monosodium urate (MSU).
Salmonella typhimurium or muramyl dipeptide, a nucleotide-
binding oligomerization domain-containing protein 2 (NOD2)
ligand, do not provoke such a response (Saitoh et al., 2008). Lig-
ands that engage TLR4 and to some extent those recognized by
TLR3, TLR7, and TLR9, but not TLR2 or TLR5, elicit enhanced
IL-1β in autophagy-deﬁcient macrophages (Saitoh et al., 2008).
In murine macrophages, excessive cytokine production follow-
ing autophagy shutdown requires TIR-domain containing adapter
inducing IFNβ (TRIF), an adapter molecule for TLR signaling
(Saitoh et al., 2008),while in human cells the response is dependent
on p38 mitogen activated protein kinase (MAPK) phosphoryla-
tion (Crisan et al., 2011). Excessive IL-1β secretion in the absence
of autophagy is not associated with alterations in NFκB activa-
tion (Saitoh et al., 2008). Importantly, exaggerated inﬂammatory
cytokine production in the absence of autophagy translates to the
development of severe disease in vivo. Atg16L1-deﬁcient mice dis-
play enhanced inﬂammatory inﬁltrates in the distal colon, elevated
IL-1β, and IL-18 serum levels and reduced survival in a dextran
Frontiers in Immunology | Antigen Presenting Cell Biology April 2012 | Volume 3 | Article 60 | 2
Mintern and Villadangos Autophagy and immunity
sulfate sodium induced model of experimental colitis (Saitoh
et al., 2008). LC3b-deﬁcient mice exhibit enhanced susceptibil-
ity to LPS-induced lethality (Nakahira et al., 2011), while both
LC3b-deﬁcient and beclin1+/− mice have increased IL-1β and IL-
18 serum levels in response to cecal ligation and puncture-induced
sepsis (Nakahira et al., 2011). In addition to IL-1β/IL-18, the type
I IFN pathway is also susceptible to modulation by autophagy.
Again the absence of a functional autophagy pathway promotes
ampliﬁed secretion of type I IFN in response to a given stimu-
lus. VSV infection of Atg5-deﬁcient murine embryonic ﬁbroblasts
(MEF) elicits increased production of IFNα, IFNβ, IL-6, and IP-
10 and as such dramatically attenuates viral replication rendering
cells resistant to infection (Jounai et al., 2007; Lee et al., 2010).
Another example is Atg9a-deﬁcient MEF that exhibit enhanced
IFNβ production in response to stimulation with inﬂammatory
double stranded DNA (Saitoh et al., 2009). Therefore, autophagy
has the potential to exert a critical inﬂuence on the regulation of
pro-inﬂammatory cytokine production and downstream effector
mechanisms of innate immunity. The ability of autophagy to limit
inﬂammatory cytokine production renders it a target pathway for
pathogens to activate as a strategy to facilitate replication. Hepati-
tis C virus (HCV) is an example of a pathogen that is proposed
to do this. If HCV infection occurs in the absence of a functional
autophagy pathway, HCV viral replication is severely attenuated
due to the corresponding activation of the type I IFN pathway.
Therefore, HCV infection elicits active autophagy in the infected
cell, limiting type I IFN production and enabling successful viral
replication (Ke and Chen, 2011). Triggering autophagy is therefore
a putative mode of immune escape.
How does autophagy act to regulate inﬂammatory cytokine
activity? Secretion of IL-1β/IL-18 is a tightly regulated process.
Pro-inﬂammatory stimuli induce the transcription of inactive
precursors pro-IL-1β or pro-IL-18. Cleavage of the inactive pro-
teins into their active secreted forms requires the assembly of
an inﬂammasome, a large protein complex that, under inﬂam-
matory conditions, processes pro-caspase-1 to caspase-1. Active
caspase-1 then cleaves pro-IL-1β and pro-IL-18 liberating the
active cytokines for secretion by the cell. In mouse cells, the lev-
els of precursor IL-1β are not altered following LPS stimulation
in the absence of autophagy (Saitoh et al., 2008), rather there
is an increase in the cleaved form of caspase-1 (Saitoh et al.,
2008; Nakahira et al., 2011). In contrast, in human cells, tran-
scription of IL-1β is elevated (Crisan et al., 2011). Autophagy
exerts its inﬂuence on IL-1β and IL-18 secretion by several mech-
anisms. A major role for autophagy in inﬂammatory cytokine
secretion is considered to be via its contribution to maintain-
ing a healthy intracellular environment. Namely, autophagy has
a pivotal role in the clearance and elimination of damaged and
dysfunctional organelles. Studies have demonstrated autophagic
degradation of depolarized mitochondria (Sandoval et al., 2008),
expanded endoplasmic reticulum (Bernales et al., 2006), mature
ribosomes (Kraft et al., 2008; Kundu et al., 2008), and excess
peroxisomes (Dunn et al., 2005). The role of autophagy in the
maintenance of mitochondrial integrity is a process known as
“mitophagy.” In the absence of functional mitophagy, cells accu-
mulate damaged mitochondria that produce high levels of reac-
tive oxygen species (ROS), a side product of cellular respiration
(Zhou et al., 2011). The accumulation of damaged mitochon-
dria is further exacerbated following stimulation with inﬂam-
matory compounds as observed for LC3b or beclin 1-deﬁcient
macrophages treated with LPS plus ATP (Nakahira et al., 2011).
Without the autophagy pathway to remove these dysfunctional
organelles, ROS levels increase (Saitoh et al., 2008), a known trig-
ger for the nucleotide binding domain, leucine rich-containing
family, pyrin domain containing 3 (NLRP3) inﬂammasome (Zhou
et al., 2011). Damaged mitochondria also display increased mem-
brane permeability with mitochondrial DNA (mtDNA) then
being able to translocate to the cytosol. mtDNA is detected in
higher abundance in the cytosol of LC3b and beclin 1-deﬁcient
macrophages, most notably following stimulation with LPS plus
ATP (Nakahira et al., 2011). As such, autophagy, by acting to
maintain turnover of damaged organelles and preserving mito-
chondrial integrity, indirectly restricts excessive inﬂammatory
cytokine production by removing endogenous triggers of the
inﬂammasome.
The second mechanism by which autophagy controls inﬂam-
matory cytokine activity is through its direct interaction with pro-
teins involved in inﬂammatory cascades. In this case, proteins are
targeted by autophagosomes or the autophagy machinery. Inter-
estingly, inﬂammasomes are engulfed and degraded by autophagy.
Following inﬂammasome induction, components of the absent
in melanoma 2 (AIM2) inﬂammasome associate with p62 and
beclin1 and exhibit K63-linked ubiquitination (Shi et al., 2012).
Other examples of the direct targeting of inﬂammatory proteins
by autophagy include the co-localization of the autophagosomal
protein LC3 and IL-1β in punctate autophagosomal structures fol-
lowing stimulation of bone marrow-derived macrophages with a
variety of TLR ligands including LPS, Pam3Cys, poly (I:C), R837,
or CpG (Harris et al., 2011). The authors suggest that autophagy
limits IL-1β secretion by facilitating its degradation in the auto-
lysosome. A direct role for autophagy in modulating components
of the type I IFN response is illustrated by several examples where
the autophagy machinery targets proteins involved in this signal-
ing cascade. Atg5–Atg12 directly interacts with the cytosolic viral
RNA sensor RIG-I and the signaling molecule IFNβ promoter
stimulator-1 (IPS-1). Interaction with Atg5–Atg12 blocks caspase
recruitment domain (CARD)-mediated signaling and the down-
stream production of type I IFN (Jounai et al., 2007). Another
interesting example is stimulator of interferon genes (STING), a
molecule critical for type I IFN signaling. Atg9a is critical for the
localization of STING to cytoplasmic punctae following treatment
of cells with dsDNA (Saitoh et al., 2009).Mislocalization of STING
to the endoplasmic reticulum results in exacerbated IFN responses
(Saitoh et al., 2009), although the speciﬁc details of why this is the
case remain to be elucidated.
Not all inﬂammatory cytokine production is enhanced in the
absence of functional autophagy. In contrast to IL-1β, IL-18 and
type I IFN, mouse tumor necrosis factor (TNF)α and IL-16 (Har-
ris et al., 2011), and human TNFα (Crisan et al., 2011) production
is inhibited when autophagy is suppressed. This is the case for
macrophages following stimulation with LPS or Pam3Cys in the
presence of 3-MA. Another example is the reduced production
of IL-8 by intestinal epithelial cells with silenced Atg7 (Li et al.,
2011b). The mechanism of why these cytokine pathways require
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autophagy may involve autophagic inhibition of p38 phospho-
rylation (Crisan et al., 2011). Therefore the role of autophagy
in modulating cytokine output is complex with its contribution
varying for individual cytokines.
Anothermechanismbywhich autophagymodulates inﬂamma-
tion is by restricting the expression of extracellular inﬂammatory
signals. During programmed cell death, autophagy enables the
generation of a cellular corpse that is efﬁciently phagocytized and
less likely to elicit detrimental inﬂammatory outcomes. This is
elegantly illustrated in a model of embryonic cavitation, where
apoptotic embryonic stem cells lacking Atg5 or beclin1 fail to
exhibit critical engulfment signals (Qu et al., 2007). These include
failing to expose phosphatidylserine (PS) at the outer membrane
and lack of secretion of the chemoattractant lysophosphatidyl-
choline.As a consequence, autophagy-deﬁcient cellular corpses are
not engulfed for clearance by immune cells. The failure to elim-
inate autophagy-deﬁcient apoptotic corpses is implicated in the
neonatal death of Atg5-deﬁcient mice. Excess apoptotic corpses
are detected in the lungs and retina, together with the presence
of an abnormal inﬂammatory inﬁltrate in these tissues. Inter-
estingly, Atg5−/− (Uhl et al., 2009), beclin1+/− (Li et al., 2008),
or Atg12−/− (Li et al., 2008) cells loaded with antigen are less
efﬁcient at facilitating DC antigen presentation to CD8+ T cells
(cross-presentation). This is postulated to be due to their poor
engulfment. The requirement for autophagy in the display of
engulfment signals is thought to be due to the pathway’s role
in maintaining cellular bioenergetics. Restoration of ATP levels
in autophagy-deﬁcient cells by treatment with methylpyruvate
restores corpse clearance (Qu et al., 2007). Induction of autophagy
indying cells also stimulates the release of immunemodulator high
mobility group B1 (HMGB1; Thorburn et al., 2009) that promotes
immunogenicity and removal of apoptotic corpses (Scafﬁdi et al.,
2002).
AUTOPHAGY AND ADAPTIVE IMMUNITY
Proteolysis provides the peptide epitopes displayed bymajor histo-
compatibility complex (MHC) molecules to elicit T cell responses.
All nucleated cells utilize the proteasome, a multiproteolytic com-
plex located in the cytosol that generates ligands for MHCI pre-
sentation. In MHCII expressing cells, lysosomal proteases generate
ligands for these molecules. Autophagy participates in generating
the pool of peptides displayed by MHCII molecules due to its
role in trafﬁcking cytosolic proteins to the lysosomes, the same
compartment where biosynthesis and loading of MHCII mole-
cules occurs. Indeed, the autophagosomal protein LC3 co-localizes
with MHCII loading compartments in DC (Schmid et al., 2007).
Fusion of inﬂuenza matrix protein M1 (Schmid et al., 2007) or
the hemagglutinin (HA) site 1 epitope (Comber et al., 2011)
to LC3 enhances their presentation by MHCII to CD4+ T cells
as a result of the intersection of autophagosomes and MHCII
loading compartments. Autophagy contribution to MHCII anti-
gen presentation is further supported by detailed analysis of the
steady state MHCII repertoire where up to a third of peptides
displayed by MHCII are shown to be derived from cytoplas-
mic or nuclear sources (Chicz et al., 1993; Dongre et al., 2001)
and would potentially rely on autophagy trafﬁcking to access the
MHCII loading compartment. Induction of autophagy increases
the relative display of these peptides compared to those derived
from membrane proteins (Dengjel et al., 2005). Peptides derived
from LC3b and gamma-aminobutyric acid receptor-associated
protein (GABARAP), components of the autophagy machinery
are eluted from MHCII molecules (Dengjel et al., 2005). There
is now a growing list of antigens that are documented as being
trafﬁcked by autophagy for MHCII display. These include self pro-
teins together with virus and bacterial-derived antigens (Munz,
2009). The role of autophagy in presenting self antigen by MHCII,
means that autophagy contributes to CD4+ T cell selection in
the thymus. Studies in which Atg5−/− thymi were grafted into
normal recipients elegantly illustrate that autophagy trafﬁcking in
thymic epithelial cells participates in the display of self antigen by
MHCII (Nedjic et al., 2008). Transplant of Atg5-deﬁcient thymi
into MHCII-restricted TCR transgenic hosts results in reduced
positive selection of HA and SEP-speciﬁc CD4+ TCR T cells.
Selection of AND, DO11.1, or DEP-speciﬁc CD4+ TCR trans-
genic T cells, on the other hand, proceeds efﬁciently in the absence
of autophagy. Autophagy is therefore considered to facilitate the
thymic MHCII presentation of some self proteins but not others.
In doing so, autophagy contributes to the complex composition
of the repertoire of MHCII epitopes that are displayed by the
thymic epithelium. The role for autophagy in thymic selection
is further evidenced by an increase in IEα52–68–IAb complexes at
the surface of cortical thymic epithelial cells that lack Atg5 (Ned-
jic et al., 2008). In this case, it is postulated that the removal of
autophagy dependent endogenous epitopes due to the absence of
Atg5, reduces competition and increases access of the IEα pep-
tide to MHCII. In addition to autophagy shaping the CD4+ T
cell repertoire that emerges from the thymus, it also participates
in effective CD4+ T cell immunity during infection. Autophagy
dependent-MHCII presentation of cytosolic model antigens has
been described for complement C5 (Brazil et al., 1997), tumor
antigen mucin 1 (Dorfel et al., 2005) and neomycin phosphotrans-
ferase (Nimmerjahn et al., 2003) where presentation is inhibited
following treatment with 3-MA. Nuclear antigen 1 of Epstein-Barr
virus (EBNA-1) is a prominent example of a viral-derived antigen
that requires autophagy for presentation byMHCII (Paludan et al.,
2005). Treatment with 3-MA or silencing of Atg12 inhibits EBNA-
1 speciﬁc CD4+ T cells from recognizing a lymphoblastoid cell
line (Paludan et al., 2005). Antigen presenting cell types that uti-
lize autophagy to deliver antigen for MHCII presentation include
B cells (Brazil et al., 1997), macrophages (Brazil et al., 1997), and
DC (Schmid et al., 2007; Jagannath et al., 2009; Lee et al., 2010).
Autophagy-mediated delivery of antigen for MHCII presentation
to CD4+ T cells means that triggering autophagy represents a
promising immunotherapeutic strategy to promote robust CD4+
T cell responses. Indeed, immunization with rapamycin-treated
DC, enhances MHCII presentation and CD4+ T cell immunity
to the anti-tuberculosis BCG vaccine antigen (Jagannath et al.,
2009). This is an exciting outcome, with major implications for
improving vaccine efﬁcacy in multiple settings.
Whether autophagy exhibits selectivity in the substrates tar-
geted is currently not well understood. This is important if the
autophagy pathway is to be manipulated for delivery of antigen to
MHCII. While basal autophagy initiated under starvation con-
ditions is considered to be a non-selective process, autophagy
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initiated under steady state conditions in immune cells is con-
sidered to be selective. A general observation is that long lived
proteins are considered to be turned over by lysosomal proteol-
ysis and hence are autophagy substrates, while the proteasome
degrades short lived polypeptides (Henell et al., 1987). Aggregates
of long lived poly-ubiquitinated proteins are known substrates of
autophagy (Mizushima and Klionsky, 2007). Of interest, protein
aggregates form in activated DC (Lelouard et al., 2002) and in
macrophages following TLR4 stimulation (Fujita et al., 2011). Sev-
eral “autophagy receptors” have been described that act to recruit
ubiquitinated proteins to autophagosomes via an LC3-interacting
motif (LIR). Known autophagy receptors identiﬁed to date include
p62/sequestosome1 (Komatsu et al., 2007), neighbour of Brca1
(NBR1) (Kirkin et al., 2009), nuclear dot protein 52kDa (NDP52)
(Thurston et al., 2009), and optineurin (Wild et al., 2011) with
all of these proteins possessing binding domains for both ubiq-
uitin (UBD) and LC3 (LIR). The interplay of these receptors in
targeting autophagy substrates is beginning to begin explored. For
example, p62, optineurin, and NDP52 all target ubiquitinated Sal-
monella enterica for destruction in lysosomes (Wild et al., 2011).
While optineurin and NDP52 colocalize, p62 binds to a separate
subdomain of the ubiquitinated bacteria. This implies selective
recognition of ubiquitin chains by speciﬁc autophagy receptors.
How upstream events regulate the activity of autophagy recep-
tors is mostly unknown. Interestingly, optineurin is subject to
phosphorylation by tank binding kinase (TBK)1, providing the
molecular trigger to promote autophagic clearance of cytosolic
bacteria (Wild et al., 2011). Identiﬁcation of a growing number
of autophagy receptors is exciting with the detail of the speciﬁc
E3 ubiquitin ligases involved, the selective recognition of ubiq-
uitin chains and their speciﬁc regulation by phosphorylation all
remaining to be further studied.
Somewhat unexpectedly, in addition to assisting the display of
cytosolic antigen byMHCIImolecules, autophagy also contributes
to the presentation of extracellular antigen and phagocytosis. Indi-
vidual components of the autophagy machinery are recruited to
phagosomes in the presence of TLR signaling. During a process
termed“LC3-associated phagocytosis (LAP)”(Sanjuan and Green,
2008), LC3 is recruited to latex-bead phagosomes in macrophages,
when beads are coupled with the TLR agonists LPS or Pam3Cys
or in response to phagosomes containing killed yeast particles
(zymosan; Sanjuan et al., 2007). LAP also contributes to the phago-
cytosis of apoptotic, necrotic, or receptor interacting kinase-3
(RIPK3)-necrotic cells with this response being triggered by the
T cell immunoglobulin and mucin domain containing molecule
(TIM)4 receptor (Martinez et al., 2011). Entosis, the engulfment
of live cells, also involves localization of LC3 to the entotic vac-
uole (Florey et al., 2011). The recruitment of LC3 to phagosomes
requires other components of the autophagy machinery given that
it does not take place in the absence of Atg5 (Sanjuan et al.,
2007; Martinez et al., 2011), Atg7 (Sanjuan et al., 2007; Mar-
tinez et al., 2011), or beclin-1 (Martinez et al., 2011). The role of
autophagy in extracellular phagocytosis and MHCII antigen pre-
sentation is evident given that Atg5-deﬁcient DC show impaired
MHCII presentation of soluble and cell-associated antigen and
elicit impaired CD4+ T cell responses in response to antigens
derived from herpes simplex virus-2 (HSV-2; Lee et al., 2010).
Infection of Atg5-deﬁcient mice with HSV-2 results in a failure
of Atg5-deﬁcient mice to mount protective CD4+ T cell immu-
nity and enhanced disease progression occurs (Lee et al., 2010).
Autophagy also contributes to exogenous processing and MHCII
presentation of HIV-1-derived protein (Blanchet et al., 2010). The
autophagy machinery is considered to contribute to phagocytosis
by facilitating phagosome to lysosome fusion and the delivery of
lysosomal proteases to phagosomes, required for effective antigen
degradation. Extracts of phagosomes isolated from Atg5-deﬁcient
DC displayed impaired cathepsin (Cat) S, CatB/L activity when
assayed with ﬂuorogenic substrates (Lee et al., 2010).
A contribution of autophagy to MHCI antigen presentation
is less obvious, given that the major proteolytic source of pep-
tide generation for MHCI is the proteasome and not lysosomal
proteases. Indeed, there are several reports discarding a role for
autophagy in MHCI presentation of antigen derived from extra-
cellular sources (cross-presentation; Blanchet et al., 2010; Lee
et al., 2010). Its role in MHCI presentation of cytosolic antigen
is less well studied. One report demonstrates the requirement for
autophagy in macrophage MHCI presentation of glycoprotein B
(gB), a HSV-1-derived protein (English et al., 2009). In this case,
treatment with 3-MA or silencing of Atg5 reduced presentation
of gB by macrophages late after infection. HSV-1 gB is proposed
to be trafﬁcked from the nuclear envelope to the autophagosome
from where its escapes for degradation by the proteasome and
MHCI display. Whether this applies only to HSV-1 infection,
macrophages, or is relevant to other antigens or cell types, remains
to be elucidated.Another example is the cross-presentationof anti-
gen loaded αAl2O3 nanoparticles (Li et al., 2011a). MHCI presen-
tation of αAl2O3 nanoparticles loaded with OVA is inhibited fol-
lowing 3-MA treatment or silencing ofAtg12 or beclin1. Themech-
anism is unknown, however internalized nanoparticles are shown
to access autophagosomes that are considered to be immunogenic
(Li et al., 2008). Autophagy may also impact MHCI presentation
by degrading MHCI molecules themselves (Li et al., 2010).
An important contribution of autophagy to adaptive immunity
is its cell intrinsic role in lymphocyte survival. An active autophagy
pathway operates in T cells, with autophagosomes detected, par-
ticularly following activation via the T cell receptor (TCR) (Espert
et al., 2006a; Li et al., 2006; Pua et al., 2007). Analysis of T cell com-
partments in Atg5-deﬁcient mice illustrates a role for autophagy
in mature T cell survival (Pua et al., 2007). While thymus cellu-
larity is reduced in the absence of Atg5, thymocyte development
is unperturbed. In the periphery, reduced numbers of CD4+ and
CD8+ T cells are present in the spleen and lymph node. The CD8+
T cell compartment is more affected, with a large proportion of
Atg5-deﬁcient CD8+ T cells staining with Annexin V, indicative
of cells undergoing early apoptosis. Both CD4+ and CD8+ T cells
that survive in the absence of Atg5 display proliferative defects
following TCR stimulation, with fewer cells undergoing division,
and fewer divisions completed in response to anti-CD3 compared
with wildtype T cells. The proliferative defect is not rescued by
anti-CD28 or IL-2 and the cells display normal levels of TCR and
upregulate T cell activation markers CD69 and CD25. A similar
phenotype is observed in Atg7ﬂ/ﬂLck-Cre mice where the speciﬁc
deletion of Atg7 in the T cell lineage results in mostly normal thy-
mocyte development, however CD4+ and CD8+ T cell numbers
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are greatly reduced in theperipheral lymphoid compartment. Both
subsets of peripheral T cells display evidence of apoptosis; with a
large proportion staining with annexin V and exhibiting caspase
9 activity. Impaired T cell survival in the absence of autophagy
is likely to arise from its pivotal role in maintaining intracellular
organelle integrity. Atg7 -deﬁcient T cells possess increased num-
bers of mitochondria and increased ROS levels (Pua et al., 2009).
For the B cell compartment, the absence of Atg5 impairs B cell
development in the bone marrow, with reduced survival of pre-B
cells and consequently reducednumbers of matureB-1a cells in the
periphery (Miller et al., 2008). In some settings autophagy facil-
itates lymphocyte death, rather than survival. Examples include
autophagy-mediated T cell death following growth factor with-
drawal (Li et al., 2006) and following binding of the HIV-1 enve-
lope protein to C-X-C chemokine receptor 4 (Espert et al., 2006b).
Therefore, autophagy serves as a critical pathway in lymphocytes
that facilitates the intricate balance between survival and death.
AUTOPHAGY AND DISEASE
The critical impact of autophagy on effector functions of innate
and adaptive immunity outlined herein, is highlighted by the
association of autophagy gene mutations with increased inci-
dence of inﬂammatory disease, susceptibility to microbial infec-
tion and autoimmune disease. A prominent example is Atg16L1,
a susceptibility gene for Crohn’s disease (Massey and Parkes,
2007), where the small intestine exhibits chronic inﬂammation
triggered by a breakdown in the clearance of commensal bacteria.
Atg16L1-deﬁcient Paneth cells possess elevated pro-inﬂammatory
cytokine transcripts, while Atg16L1-deﬁcient mice develop exac-
erbated intestinal inﬂammation following environmental triggers,
similar to that observed in human patients (Cadwell et al., 2008).
Other examples include cystic ﬁbrosis, a chronic inﬂammatory
disease of the pulmonary airways, where autophagy-mediated
maintenance of lung epithelial cell homeostasis is important
to limit lung inﬂammation and disease (Luciani et al., 2010).
Autophagy is also postulated to contribute to inﬂammation-
associated responses underlyingmetabolic diseases, such as obesity
(Yang et al., 2010). In infectious disease settings, mouse models
illustrate a contribution of autophagy to a growing number of
microbial pathogens. IRGM, a human immunity-related GTPase
that plays a critical role in regulating autophagy-mediated clear-
ance of mycobacteria, is a genetic risk factor for tuberculosis
(Intemann et al., 2009). Finally, a link between single nucleotide
polymorphisms in the Atg5 gene and susceptibility to systemic
lupus erythematosus, a debilitating autoimmune disease has been
reported (Gateva et al., 2009). The emergence of often surprising
roles for autophagy in diseases of the immune system means that
a wide range of immune-related diseases may now be amenable
to targeting by autophagy modulating drugs. As such studies
of autophagy in innate and adaptive pathways provide excellent
insights into this complex pathway, uncovering new roles for
autophagy in disease.
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